ANI PHARMACEUTICALS, INC Retail Related Inventory, Packaging and Other Supplies
ANI PHARMACEUTICALS, INC (ANIP) had Retail Related Inventory, Packaging and Other Supplies of $9.74 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Inventory
us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies · last filed 2026-02-27
- 2025-12-31: Retail Related Inventory, Packaging and Other Supplies $9.74M.
- 2025-09-30: Retail Related Inventory, Packaging and Other Supplies $9.71M.
- 2025-06-30: Retail Related Inventory, Packaging and Other Supplies $9.93M.
- 2025-03-31: Retail Related Inventory, Packaging and Other Supplies $11.12M.
| Period end | Retail Related Inventory, Packaging and Other Supplies | Retail Related Inventory, Packaging and Other Supplies as first filed |
|---|---|---|
| 2025-12-31 | $9.74M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $9.71M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $9.93M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $11.12M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $9.98M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $10.52M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $10.43M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $9.85M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $9.62M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $8.87M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $8.08M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $7.78M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $7.72M 10-K · filed 2024-02-29 | $7.76M 10-K · filed 2023-03-09 |
| 2022-09-30 | $7.87M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $6.41M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $5.56M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $5.47M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.63M 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $3.35M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $3.07M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $3.19M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $3.14M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.04M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.88M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.90M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $2.96M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $2.49M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $2.72M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.56M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $2.28M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.86M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.62M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.53M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $1.36M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.28M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.08M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $930.00K 10-K · filed 2018-02-27 | |
| 2016-09-30 | $1.12M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $935.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $784.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $998.00K 10-K · filed 2017-03-02 | |
| 2015-09-30 | $1.02M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $922.00K 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $783.00K 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $794.00K 10-K · filed 2016-02-23 | |
| 2014-09-30 | $671.00K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $784.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $732.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $766.00K 10-K · filed 2015-02-23 | |
| 2013-09-30 | $650.06K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $586.83K 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $585.00K 10-K · filed 2014-02-28 | $584.65K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |